BRIAN MCARTHUR: Open Payments
NPI 1588196026 · DURAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 45 payments from 15 companies in 2025. Trend: 2023 $666 · 2024 $766 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $175 |
| Novo Nordisk Inc | 10 | $165 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| ABBVIE INC. | 4 | $75 |
| Lundbeck LLC | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $29 |
Products named: REXULTI, BREZTRI, CAPLYTA, Wegovy, AIRSUPRA, FARXIGA, VOQUEZNA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
